News
DVAX
11.61
+1.13%
0.13
Weekly Report: what happened at DVAX last week (0715-0719)?
Weekly Report · 4d ago
3 'Strong Buy' Small-Caps With 27% to 146% Upside Potential
Three small-cap stocks have captured significant bullish sentiment. Hillenbrand, Inc., Helix Energy Solutions Group, Inc. And Dynavax Technologies Corporation are all components of the S&P Smallcap 600 Index. Small-cap companies are gaining attention due to speculation of falling interest rates. The three companies have consensus "Strong Buy" ratings.
Barchart · 4d ago
Weekly Report: what happened at DVAX last week (0708-0712)?
Weekly Report · 07/15 09:25
Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Dynavax Technologies Corporation (NASDAQ:DVAX) has US$223.0m of debt on its balance sheet. The company uses debt to fund growth, but it does not have a heavy debt load. The balance sheet shows that the company has plenty of cash to offset the debt. However, debt is often used to fund a company when it goes bankrupt. Dynavax has a high level of debt, but is not considered to be risky in the near term.
Simply Wall St · 07/12 14:31
New Strong Sell Stocks for July 9th
NASDAQ · 07/09 11:22
Weekly Report: what happened at DVAX last week (0701-0705)?
Weekly Report · 07/08 09:25
Weekly Report: what happened at DVAX last week (0624-0628)?
Weekly Report · 07/01 09:25
Dynavax Price Target Maintained With a $29.00/Share by HC Wainwright & Co.
Dow Jones · 06/28 10:38
HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Benzinga · 06/28 10:28
Dynavax’s Promising Vaccine Trials and Financial Outlook Merit a Buy Rating
TipRanks · 06/28 10:16
DYNAVAX TECHNOLOGIES CORP: ANTICIPATES REPORTING TOP LINE IMMUNOGENICITY AND SAFETY DATA IN SECOND HALF OF 2025
Reuters · 06/27 20:09
Dynavax Technologies (NASDAQ:DVAX): A Promising Biopharma Option Despite Recent Challenges
TipRanks · 06/27 10:42
Weekly Report: what happened at DVAX last week (0617-0621)?
Weekly Report · 06/24 09:27
Look Under The Hood: IJR Has 17% Upside
NASDAQ · 06/17 12:44
Weekly Report: what happened at DVAX last week (0610-0614)?
Weekly Report · 06/17 09:25
Dynavax, Bloomin Brands, and Premier are the most shorted small-cap stock in May - Hazeltree report
Dynavax, Bloomin Brands, and Premier are the most shorted small-cap stock in May - Hazeltree report. DVAX, BLMN, and PINC are down nearly 32% and 17.5% year-to-date.
Seeking Alpha · 06/11 16:40
Weekly Report: what happened at DVAX last week (0603-0607)?
Weekly Report · 06/10 09:26
Weekly Report: what happened at DVAX last week (0527-0531)?
Weekly Report · 06/03 09:27
Dynavax to Present at Upcoming Investor Conferences
Barchart · 05/28 15:18
Weekly Report: what happened at DVAX last week (0520-0524)?
Weekly Report · 05/27 09:27
More
Webull provides a variety of real-time DVAX stock news. You can receive the latest news about Dynavax Technolo through multiple platforms. This information may help you make smarter investment decisions.
About DVAX
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company, which is engaged in developing and commercializing vaccines. The Company's products include HEPLISAV-B hepatitis B vaccine and CpG 1018. Its HEPLISAV-B ((Recombinant)(Adjuvanted) is indicated for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. It also manufactures and sells CpG 1018 adjuvant, the adjuvant used in HEPLISAV-B. It is also engaged in developing a multi-program clinical pipeline leveraging CpG 1018 adjuvant to develop improved vaccines for indications with unmet medical needs. Its Pipeline programs include vaccine candidates under development for shingles, tetanus, diphtheria, and pertussis (Tdap) and plague. Its Shingles vaccine program Z-1018, which is an investigational vaccine candidate being developed for the prevention of shingles in adults aged 50 and older.